FMC is a pure-play crop protection company that develops and sells insecticides, herbicides, and fungicides to protect crops from insects, weeds, and disease, along with a smaller plant health segment covering biologicals, crop nutrition, and seed treatments. FMC's most important product is Rynaxypyr, a diamide insecticide that is the world's leading insect control technology, generating roughly $800M in annual revenue. A second diamide, Cyazypyr, generates roughly $400M in revenue with longer-lasting patent protection. FMC sells products through distributors, retailers, cooperatives, and directly to large growers, operating across North America, Latin America, EMEA, and Asia. Brazil is FMC's largest individual market. FMC's portfolio divides into a core portfolio of Rynaxypyr and legacy off-patent products facing generic competition, and a growth portfolio of Cyazypyr, four newly commercializing active ingredients, and plant health. The four new molecules — fluindapyr (fungicide), Isoflex (herbicide), Dodhylex (herbicide with a new mode of action), and Rimisoxafen (dual mode-of-action herbicide) — generated roughly $200M combined in 2025, with FMC targeting over $2B in peak annual sales by 2035. FMC also sells Rynaxypyr and Cyazypyr to competitor agrochemical companies under long-term supply contracts. With Rynaxypyr's patents now expired, FMC is restructuring its manufacturing footprint to cut costs on uncompetitive legacy production, while shifting mix toward patented advanced formulations. FMC's board has also authorized exploring a sale of the company.